Licoxia 90 Tablet contains Etoricoxib 90 mg, a selective cyclooxygenase-2 (COX-2) inhibitor used primarily for the management of pain and inflammation associated with various musculoskeletal and inflammatory conditions. Etoricoxib exerts its therapeutic effects by selectively inhibiting the COX-2 enzyme, thereby reducing the synthesis of prostaglandins involved in pain and inflammation, while sparing COX-1, which helps minimize gastrointestinal adverse effects commonly seen with non-selective NSAIDs. Licoxia 90 is indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, and chronic low back pain. It provides effective analgesia and anti-inflammatory benefits, improving patient mobility and quality of life. The recommended dose should be individualized based on the severity of the condition and patient response, with careful consideration of contraindications such as hypersensitivity to Etoricoxib, active peptic ulcer disease, severe hepatic or renal impairment, and cardiovascular risk factors. Caution is advised in patients with hypertension or heart failure. Common side effects may include headache, dizziness, gastrointestinal discomfort, and elevated liver enzymes. Licoxia 90 should be used under medical supervision, with periodic monitoring to ensure safety and efficacy during prolonged therapy.